Primary Site >> Colorectal Cancer
Gene >> CPT2
| 1. | |||||||||||
| Journal: | Drugs. 1996 Oct;52(4):606-23. | ||||||||||
| Title: | Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer. | ||||||||||
| Author: | Wiseman, L R|Markham, A | ||||||||||
| PMID: | 8891470 | ||||||||||
| 2. | |||||||||||
| Journal: | Eur J Cancer. 1996;32A Suppl 5:S23-7. | ||||||||||
| Title: | A glimpse of the future. new directions in the treatment of colorectal cancer. | ||||||||||
| Author: | Van Cutsem, E | ||||||||||
| PMID: | 8958039 | ||||||||||
| 3. | |||||||||||
| Journal: | Semin Oncol. 1998 Oct;25(5 Suppl 11):39-46. | ||||||||||
| Title: | Efficacy and toxicity of irinotecan in patients with colorectal cancer. | ||||||||||
| Author: | Rothenberg, M L | ||||||||||
| PMID: | 9786315 | ||||||||||
| 4. | |||||||||||
| Journal: | Oncotarget. 2017 May 15;8(37):61107-61117. | ||||||||||
| Title: | Integrated transcriptomic analysis of distance-related field cancerization in rectal cancer patients. | ||||||||||
| Author: | Guo, Honglin|Zeng, Weigen|Feng, Lin|Yu, Xuexin|Li, Ping|Zhang, Kaitai|Zhou, Zhixiang|Cheng, Shujun | ||||||||||
| PMID: | 28977850 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncotarget. 2017 Nov 10;8(61):104508-104524. | ||||||||||
| Title: | hsa-miR-29c-3p regulates biological function of colorectal cancer by targeting SPARC. | ||||||||||
| Author: | Zhang, Shitong|Jin, Jianjun|Tian, Xiaoxiao|Wu, Lijuan | ||||||||||
| PMID: | 29262657 | ||||||||||
| 6. | |||||||||||
| Journal: | Oncol Lett. 2018 Jul;16(1):48-54. | ||||||||||
| Title: | Transcriptome profiling analysis reveals biomarkers in colon cancer samples of various differentiation. | ||||||||||
| Author: | Yu, Tonghu|Zhang, Huaping|Qi, Hong | ||||||||||
| PMID: | 29928385 | ||||||||||